https://clinicaltrials.gov/ct2/show/NCT03734588?type=Intr&cond=hemophilia&lupd_s=02%2F27%2F2019&lupd_d=14
Conditions : Adeno-Associated Virus (AAV); Blood Coagulation Disorder; Blood Coagulation Disorders, Inherited; Coagulation Protein Disorders; Factor VIII (FVIII); Factor VIII (FVIII) Deficiency; Factor VIII (FVIII) Gene; Factor VIII (FVIII) Protein; Genetic Diseases, Inborn; Genetic Diseases, X-Linked; Gene Therapy; Gene Transfer; Hematologic Diseases; Hemorrhagic Disorders; Recombinant; Vector; Inhibitors
Intervention : Genetic: SPK-8016
Sponsor : Spark Therapeutics
Recruiting
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
NCT03734588
Thu, 08 Nov 2018 12:00:00 EST
Last Update Posted: 03/13/19 10:19AM
